(Q66083318)

English

Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Multicenter, Randomized, Double-blind, Parallel-controlled Phase 3 Study Evaluating the Efficacy and Safety of Recombinant Human Monoclonal Antibody Against Human Tumor Necrosis Factor-α (IBI303) Compared to Adalimumab in Patients With Active Ankylosing Spondylitis (English)

0 references

medical condition

spondylitis

0 references

start time

22 September 2016

0 references

end time

22 January 2018

0 references

number of participants

438